Enanta Pharma (ENTA) Tops Q1 EPS by 39c
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Join SI Premium – FREE
Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($0.42), $0.39 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $18.6 million versus the consensus estimate of $16.05 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Sadot Group names Michael Murray as CEO and CFO
- Burford Capital closes $300M debt issuance, retires 2028 maturity early
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
